Saturday, October 15, 2022 from 9:45 AM to 11:15 AM PDT at Continental Ballroom 6
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-144-L01-P
Activity Type: An Application-Based Activity
This session will have 3 speakers who will highlight global antimicrobial resistance concerns, review the new antimicrobials, and discuss evidence to optimize antimicrobial therapy. The first presentation will outline the global contributors to antimicrobial resistance. The purpose of this program is to highlight global targets for antimicrobial stewardship interventions and highlight strategies that can be used in resource limited treatment settings. The second presentation will review management strategies when faced with resistant bacterial infections. This session aims to highlight global threats in terms of resistance patterns, incorporation of newer antibacterial agents, and identifying the place for older antimicrobial options. The third presentation will discuss antimicrobial stewardship strategies that can be incorporated into practice in all practice settings. This session looks to focus on the selection of patients that are candidates for oral therapy, appropriate selection of short course antimicrobial regimens, and incorporation of rapid diagnostics to shorten the time to definitive antimicrobial therapy.
 | Moderator: Khalid Eljaaly, Pharm.D., BCIDP, BCPS
Associate Professor, Faculty of Pharmacy, and Head of Health Interprofessional Research Branch, King Abdulaziz University, Jeddah, Saudi Arabia
Infectious Disease Pharmacy Consultant and Director of Infectious Disease Pharmacy Residency, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
Honorary Research Fellow, College of Pharmacy, University of Arizona, Tucson, AZ, United States
Chairman of Infectious Disease Pharmacy Practice Network of Saudi Society of Clinical Pharmacy
View Biography |
Learning Objectives
1. Describe antibiotic stewardship strategies for pharmacists in resource limited settings.
2. Analyze strategies to assist pharmacists in resource limited settings to develop an antimicrobial stewardship program.
3. Assess antimicrobial stewardship strategies that can impact global contribution to antibiotic resistance.
4. Identify difficult to treat pathogens that are recognized as global threats.
5. Construct antimicrobial regimens using novel agents to manage resistant bacterial infections.
6. Evaluate the role of timeworn antimicrobial agents in the treatment of resistant infections.
7. Incorporate rapid diagnostic testing in practice to shorten time to definitive therapy.
8. Apply current evidence to define the optimal antimicrobial treatment duration.
9. Select patients receiving intravenous antibiotics that are eligible for oral step-down therapy.